4
Changes in Ownership
Organogenesis Holdings Inc. Filed Acc 0001062993-23-004888
Chief Financial Officer acquired 242,508 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Francisco David Chief Financial Officer | 2023-02-22 | Grant or award | +242,508 | 291,929 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Francisco David Chief Financial Officer | 2023-02-22 | Grant or award · Stock Option (Right to Buy) | +287,892 | 287,892 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…